Hmmm..... now you're embarrassing me! I told everybody you do serious research, and now you're coming up with half-baked?!
The stethoscope isn't an alternative. At best a doctor can use it to eliminate some conditions and form an opinion about what the most likely diagnoses are. But the ResappDx targets are beyond unequivocal diagnosis on sound alone using human hearing and judgement, except for practitioners with substantial skill and experience.
The market size, location and revenue model are all in the investor presentation. How about you do some of that research I praised you for earlier?
- Forums
- ASX - By Stock
- RAP
- Ann: Positive Results from Australian Adult Clinical Studies
Ann: Positive Results from Australian Adult Clinical Studies, page-55
Currently unlisted. Proposed listing date: 4 SEPTEMBER 2024 #
-
-
- There are more pages in this discussion • 17 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)